Skip to main content

Table 1 Characteristics of pediatric cases caused by Chryseobacterium indologenes

From: Ventilator-associated pneumonia caused by Chryseobacterium indologenes: a rare infant case and review of the literature

No

Age/sex

Underlying condition

Medical device

Infection type

Treatment

Outcome

Year/reference

1

1 year/M

Burn

Ventilator

VAP

Ciprofloxacin, cefoxitin, amikacin

Died

1996/Hsueh et al. (1996)

2

5 year/F

Neuroblastoma

CVC

Bacteremia

NR

Survived

1996/Hsueh et al. (1996)

3

1 year/F

Hepatoblastoma

CVC

Bacteremia

NR

Survived

1996/Hsueh et al. (1996)

4

2 year/M

Diabetes mellitus (Type 1)

Peripheral catheter

Bacteremia

Ceftriaxone

Survived

2005/(Cascio et al. 2005)

5

5 month/M

Down syndrome, diaphragmatic hernia, ASD

Ventilator

Bacteremia

Vancomycin, ofloxacin

Died

2007/(Bayraktar et al. 2007)

6

13 year/M

Congenital hydrocephalus

Lumboperitoneal shunt

Lumboperitoneal shunt infection

TMP–SMX, Rifampin

Survived

2007/(Al-Tatari et al. 2007)

7

33 day/F

None

None

Bacteremia

Cefepime

Survived

2010/(Douvoyiannis et al. 2010)

8

2 month/M

Hydrocephaly

External shunt

Meningitis, sepsis

Ampicillin–sulbactam, levofloxacin

Died

2011/(Ceylan et al. 2011)

9

36 week newborn/NR

Prematurity

Ventilator

Bacteremia

Cefoperazone–sulbactam

Survived

2011/(Sudharani and Asiya Saxena 2011)

10

20 day/M

Complex congenital heart disease

Ventilator

VAP

Piperacillin–tazobactam

Survived

2011/(Calderón et al. 2011)

11

8 day/F

None

None

Meningitis

Cefepime

Survived

2013/(Hendaus and Zahraldin 2013)

12

3 year/F

Acute myeloid leukemia

CVC

CRBSI

Ciprofloxacin, minocycline

Survived

2013/(Kodama et al. 2013)

13

6 month/M

Congenital hydrocephalus, prematurity

Ventriculoperitoneal shunt

Meningitis

TMP–SMX, cefoperazone–sulbactam

Survived

2013/(Ozcan et al. 2013)

14

11 month/M

Holoprosencephaly, obstructive hydrocephalus

Ventriculoperitoneal shunt

Meningitis

TMP–SMX, ceftazidime

Survived

2014/(Olbrich et al. 2014)

15

6 day/F

SGA

None

Meningitis, sepsis

Ciprofloxacin, TMP–SMX

Survived

2014/(Eshwara et al. 2014)

16

3 month/F

ASD

CVC

Bacteremia

TMP–SMX

Survived

2014/(Aydin et al. 2014)

17

27 week newborn/F

Complex congenital heart disease

Central catheter, arterial and venous line

Bacteremia

Ciprofloxacin, imipenem

Survived

2014/(Alford and Shelton 2014)

18

3 month/M

Metabolic disease

CVC, ventilator

CRBSI

Ciprofloxacin, imipenem, colimycin, linezolid

Died

2016/(Aykac et al. 2016)

19

2 year/F

Congenital hydrocephalus

External shunt

Meningitis

Ciprofloxacin, TMP–SMX

Survived

2016/(Aykac et al. 2016)

20

8 year/M

Cystic fibrosis, nephrotic syndrome

None

Pneumonia

Ceftriaxone

Survived

2016/(Aykac et al. 2016)

21

8 month/M

Ileus

CVC

Bacteremia

Ciprofloxacin, meropenem, vancomycin

Survived

2016/(Aykac et al. 2016)

22

16 month/F

ITP, immunosuppressive therapy

None

Bacteremia

Ceftriaxone

Survived

2016/(Aykac et al. 2016)

23

3 year/F

Cerebral palsy

CVC

CRBSI

Meropenem, amikacin

Survived

2016/(Aykac et al. 2016)

24

11 year/F

None

None

Soft tissue infection

Ceftazidime, metronidazole

Survived

2016/(Srinivasan et al. 2016)

25

3 month/F

Meningomyelocele, congenital diaphragmatic hernia

Ventilator

VAP

Ciprofloxacin

Survived

Our case

  1. M male, F female, NR not reported, TMPSMX Trimethoprim–Sulfamethoxazole, VAP ventilator-associated pneumonia, CVC central venous catheter, CRBSI catheter-related blood stream infection, SGA small for gestational age, ASD atrial septal defect, ITP immune thrombocytopenic purpura